GramEye Inc. CEO Yu Hiraoka Speaks as Panelist at International Symposium "STS forum Japan – Thailand Symposium 2026"
NQ Score
0/100
N1 Content Completeness
90
Key facts
- GramEye Inc. CEO Yu Hiraoka Speaks as Panelist at International Symposium "STS forum Japan – Thailand Symposium 2026"
- GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."
- Source: PR TIMES
- Date: Thu May 07 2026 23:10:02 GMT+0900 (Japan Standard Time)
Direct answer
GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."
- Citation
- GramEye Inc. CEO Yu Hiraoka Speaks as Panelist at International Symposium "STS forum Japan – Thailand Symposium 2026" (Thu May 07 2026 23:10:02 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Thu May 07 2026 23:10:02 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."
- Q: What is the direct answer?
- A: GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."
- Q: What is the source and date?
- A: Source: https://prtimes.jp/main/html/rd/p/000000014.000098814.html | Date: Thu May 07 2026 23:10:02 GMT+0900 (Japan Standard Time)